Lupus pneumonitis or severe acute respiratory syndrome?

Abstract

Severe acute respiratory syndrome (SARS) is a serious respiratory illness caused by a novel human coronavirus. The disease is highly infectious and carries significant mortality and morbidity. There was a major outbreak of SARS in Guangdong, Taiwan, Beijing, Hong Kong and Toronto between March and June 2003. Common presenting features of SARS are high fever, chills, rigor, malaise, nonproductive cough, lymphopenia and pulmonary infiltrates, followed by rapidly progressive respiratory failure in some cases. We describe two patients with systemic lupus erythematosus (SLE) who presented with fever, systemic upset and pulmonary infiltrates between April and June, 2003. One patient was confirmed to have coronavirus pneumonia while the other had active SLE with lung involvement. Our cases illustrate the difficult diagnostic dilemma in the evaluation of febrile SLE patients during the SARS epidemic.

Keywords

atypical pneumonia Chinese coronavirus epidemic infection morbidity

Get full access to this article

View all access options for this article.

References

Holmes KV. SARS coronavirus: a new challenge for prevention and therapy . J Clin Invest 2003; 111: 1605-1609 .

Zhao Z , Zhang F , Xu M et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China . J Med Microbiol 2003; 52: 715-720 .

Lee N , Hui D , Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong . N Engl J Med 2003; 348: 1986-1994 .

Booth CM , Matukas LM , Tomlinson GA et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area . JAMA 2003; 289: 2801-2809 .

World Health Organization . Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en (last accessed on July 26, 2003).

Rainer TH , Cameron PA , Smit D et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study . Br Med J 2003; 326: 1354-1358 .

Center for Disease Control and Prevention . Updated Interim US Case Definition for Severe Acute Respiratory Syndrome (SARS). Available at: http://www.cdc.gov/ncidod/sars/casedefinition.htm (last accessed on July 26, 2003).

Wong RS , Wu A , To KF et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis . Br Med J 2003; 326: 1358-1362 .

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

10.

Maeda N , Sekigawa I , Iida N , Matsumoto M , Hashimoto H , Hirose S. Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus . Scand J Rheumatol 1999; 28: 166-170 .

11.

Cheema GS , Quismorio FP Jr. Interstitial lung disease in systemic lupus erythematosus . Curr Opin Pulm Med 2000; 6: 424-429 .

12.

Orens JB , Martinez FJ , Lynch JP 3rd. Pleuropulmonary manifestations of systemic lupus erythematosus . Rheum Dis Clin North Am 1994; 20: 159-193 .

13.

Min JK , Hong YS , Park SH et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus . J Rheumatol 1997; 24: 2254-2257 .

14.

Muller NL , Ooi GC , Khong PL , Nicolaou S. Severe acute respiratory syndrome: radiographic and CT findings . Am J Roentgenol 2003; 181: 3-8 .

15.

Nicholls JM , Poon LL , Lee KC et al. Lung pathology of fatal severe acute respiratory syndrome . Lancet 2003; 361: 1773-1778 .

16.

Ding Y , Wang H , Shen H et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China . J Pathol 2003; 200: 282-289 .